A Conversation on Diversity

• Industry Reports
• 2025

Washington State Life Science Investment Report – May 2025

• Industry Reports
• 2025

Washington State Life Science Investment Report – April 2025

• Policy Blog
• 2025

Policy Blog – May 23, 2025 – House Bill Moves to Restore Immediate R&D Expensing — A Critical Step Forward

The reconciliation bill passed by the House this week includes a fix Life Science Washington and many others in our industry have been advocating for: restoring immediate expensing for R&D costs. Since the change to Section 174 of the tax code took effect in 2022, companies have been required to amortize R&D expenses over five […]

• Policy Blog
• 2025

Policy Blog – May 12, 2025 – Washington’s 2025 Legislative Session Ends with High Stakes and Hard-Fought Compromises

The 2025 Washington legislative session adjourned Sine Die on April 28 after 105 days of intense policymaking and budget negotiations. Despite expanded Democratic majorities, deep divisions over how to close a $16 billion deficit—driven by years of overspending and reliance on one-time federal funds—created frequent clashes within and across party lines, and with newly elected […]